Uncategorized
Surgery plays role in DME cases unresponsive to pharmacotherapy
VIENNA, Austria — Vitrectomy may still have a role in treating diabetic macular edema in patients who do not respond to treatment with anti-VEGFs or steroids, according to a specialist.“Vitrectomy may be an option for nonresponders to pharmacological therapies,” Anat Loewenstein, MD, said at the Advanced Retinal Therapy meeting, citing studies showing that a proportion of patients on such therapies have poor gain of vision or lose vision.